Insulin resistance, blood sugar regulation, metabolic syndrome, and body composition
413 artigos
A 6-month AI-driven personalized diet intervention cut BMI by 33% and reduced biological age by 8 years in morbidly obese patients.
A sweeping review of GLP-1 agonists, tirzepatide, and emerging hormone combos reshaping obesity treatment in 2025.
The TRIUMPH program tests retatrutide across 5,800+ patients using a novel basket trial design to simultaneously tackle obesity and its complications.
Um mergulho profundo em nível molecular sobre a cinética de formação de AGEs, isoformas de RAGE, redes transcricionais a jusante e intervenções baseadas em evidências — para quem deseja o quadro mecanístico completo.
Baxdrostat becomes the first-in-class aldosterone synthase inhibitor approved to treat resistant hypertension alongside existing drugs.
Vá além do básico e explore os mecanismos bioquímicos por trás da glicação — da cascata da reação de Maillard à sinalização RAGE e ao entrecruzamento tecidual — para entender por que os AGEs são centrais para o envelhecimento e as doenças metabólicas.
Descubra como as moléculas de açúcar danificam silenciosamente suas proteínas e células ao longo do tempo — e o que você pode fazer para desacelerar esse processo de envelhecimento sorrateiro.
FDA approval of the first T1D delay drug nearly doubled islet autoantibody testing, but critical gaps remain in screening healthy children.
A new review links feline age-related obesity to SASP-driven chronic inflammation, offering translational insights for human metabolic disease.
The triple agonist retatrutide drives deep metabolic shifts beyond weight loss, improving key biomarkers of cardiovascular and insulin health.
Scientists identify IL-11 as a molecular brake on beige fat thermogenesis, and show blocking it improves metabolism in obese mice.
Diabetes drugs like empagliflozin show surprising anti-aging effects — mimicking caloric restriction and reducing senescent cell burden.
